COTY
Coty Inc. Consumer Staples Perfumes, Cosmetics & Other Toilet Preparations Russell 3000
$3.40Close
$3.0BMarket cap
$1.85 – $3.9752-week range
Nov 4, 2026Next report · after the close
Highlights
Cautions
- Trend not confirmed 6 of 8 conditions · 150-day under the 200-day, 200-day not rising
- Extended 5.0 ATR above its 50-day average
- Results soon Nov 4, 2026, in 3 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
14%
1wk
up 5.3%
price change
1mo
up 30.3%
price change
12-month return
down 13%
market up 11% ·
its own down 25%
F-score
3 / 9
Weak
Altman Z
-0.07
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
1.0×
price / book
Earnings yield
down 1.4%
EBIT / enterprise value
Cheaper than
68%
of the market · cheap
Revenue growth
down 1%
year on year
EPS growth
—
latest quarter
Sales growth
up 1%
latest quarter · +3 pts
ROE
down 19%
return on equity
Free cash margin
up 6%
$348.2M FCF
D/E
1.01
long-term debt / equity
Net debt / EBITDA
7.1×
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- short-term liquidity weakened
- issued more shares
- gross margin narrowed
- assets working less efficiently
- generating cash from operations
- profits backed by cash
- reduced long-term debt
Repair signals
- Long-term debt down 23% ($4.0B → $3.0B)
Trade setup
ATR%
3.8%
$0.13 a day · 2×ATR $3.14
RS
70 / 99
vs the universe
Trend
6 / 8
150-day under the 200-day, 200-day not rising
Relative volume
0.8×
vs 50-day average
Up/down volume
1.43
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 6 of 8
- 150-day average above the 200-day: fails
- 200-day average rising for a month: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Heavily indebted Net debt is 7.1 times EBITDA — roughly 7 years of earnings before interest, tax and depreciation to repay borrowings in full.
- Gross margin narrowing Gross margin fell from 64.8% to 62.9%. The company is keeping less of each dollar of sales than it did a year ago.
- Revenue shrinking Revenue fell 1.5% over the year, from $5.9B to $5.8B.
Last reported
Aug 19, 2026
Results reaction
Aug 19, 2026+1% vs market2 sessions after results
Financials
- Gross 63%
- Net -11%
- Free cash 6%
- Cash
- Long-term debt
| FY2021Jun 30, 2021 | FY2022Jun 30, 2022 | FY2023Jun 30, 2023 | FY2024Jun 30, 2024 | FY2025Jun 30, 2025 | FY2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $5.3B | $5.6B | $6.1B | $5.9B | $5.8B |
| Gross margin | 60% | 64% | 64% | 64% | 65% | 63% |
| Operating income | -$48.6M | $240.9M | $543.7M | $546.7M | $241.1M | -$81.5M |
| Net income | -$201.3M | $55.5M | $495.0M | $76.2M | -$381.1M | -$618.0M |
| Net margin | -4% | 1% | 9% | 1% | -6% | -11% |
| Earnings per share | -$0.26 | $0.07 | $0.56 | $0.09 | -$0.44 | -$0.70 |
| Free cash flow | $144.8M | $552.5M | $402.9M | $369.4M | $277.6M | $348.2M |
| Free cash margin | 3% | 10% | 7% | 6% | 5% | 6% |
| Cash | $253.5M | $233.3M | $246.9M | $300.8M | $257.1M | $176.1M |
| Long-term debt | $5.4B | $4.4B | $4.2B | $3.8B | $4.0B | $3.0B |
| Shareholders' equity | $2.9B | $3.2B | $3.8B | $3.8B | $3.5B | $3.0B |
| Shares outstanding | 766m | 839.20m | 852.80m | 867.80m | 872.30m | 880.50m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 20, 2026 | Annual ↗ | Jun 30, 2026 | 51d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 5, 2026 | Quarterly ↗ | Dec 31, 2025 | 36d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 21, 2025 | Annual ↗ | Jun 30, 2025 | 52d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 10, 2025 | Quarterly ↗ | Dec 31, 2024 | 41d |
| Nov 6, 2024 | Quarterly ↗ | Sep 30, 2024 | 37d |
| Aug 20, 2024 | Annual ↗ | Jun 30, 2024 | 51d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 8, 2024 | Quarterly ↗ | Dec 31, 2023 | 39d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Sep 11, 2026 | Director or officer change ↗ |
| Aug 20, 2026 | Director or officer change ↗ |
| Aug 19, 2026 | Results ↗ |
| Jul 7, 2026 | Other events ↗ |
| Jul 2, 2026 | Director or officer change ↗ |
| May 5, 2026 | Results ↗ |
| Mar 18, 2026 | Director or officer change · Regulation FD ↗ |
| Feb 5, 2026 | Results ↗ |
| Dec 22, 2025 | Director or officer change ↗ |
| Dec 19, 2025 | Material agreement · Impairment · Other events ↗ |
| Nov 12, 2025 | Shareholder vote ↗ |
| Nov 5, 2025 | Results ↗ |